Valensi, Paul

Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments

Tesfaye, S., Boulton, A. J. M., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R. A., Spallone, V., Vinik, A., et al. (2010) · Diabetes Care

Pain Mechanisms and TreatmentsPeripheral Neuropathies and Disorders

Cited by 2,690

Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management

Spallone, V., Ziegler, D., Freeman, R., Bernardi, L., Frontoni, S., Pop‐Busui, R., Stevens, M., Kempler, P., Hilsted, J., Tesfaye, S., et al. (2011) · Diabetes/Metabolism Research and Reviews

Cardiovascular Syncope and Autonomic DisordersHeart Rate Variability and Autonomic Control

Cited by 957

The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation

Fruchart, J.-C., Santos, R. D., Aguilar-Salinas, C., Aikawa, M., Al Rasadi, K., Amarenco, P., Barter, P. J., Ceska, R., Corsini, A., Després, J.-P., et al. (2019) · Cardiovascular Diabetology

Peroxisome Proliferator-Activated ReceptorsLipoproteins and Cardiovascular Health

Cited by 140

Agonistes du récepteur du GLP1 (AR-GLP1) et dérivés, vidange gastrique et anesthésie

Benhamou, D., Catargi, B., Cheisson, G., Cosson, E., Ichai, C., Jacqueminet, S., Ouattara, A., Tauveron, I., & Valensi, P. (2023) · Anesthésie & Réanimation

Diabetes Treatment and ManagementAnesthesia and Sedative Agents

Cited by 1